AlphaGen Therapeutics is pioneering the discovery, development and commercialization of innovative radioligand therapies (RLTs). With our cutting-edge technology platform, we are developing a new class of alpha RLTs for patients in China and around the world.
Investors 2
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| 22.05.2026 | Eight Road... | eightroads... |
Mentions in press and media 3
| Date | Title | Description |
| 20.04.2026 | AlphaGen Therapeutics to Present Preclinical Studies of Two Next-Generation Alpha Therapies at AACR 2026 | SHANGHAI, April 20, 2026 /PRNewswire/ -- AlphaGen Therapeutics (AlphaGen), a biopharmaceutical company that focuses on developing next-generation targeted alpha radiotherapies, today announced that it will present preclinical data on two ad... |
| 28.02.2024 | ARTBIO Collaborates with AlphaGen Therapeutics, and Enters into Three Strategic Agreements to Produce its Lead Asset AB001 | - |
| 20.02.2024 | AlphaGen Therapeutics and ARTBIO Announce Exclusive Strategic Collaboration for the Development and Commercialization of AB001 in Greater China and on ARTBIO’s 212Pb AlphaDirect™ Technology | - |